Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Palvella Therapeutics
Entity

Palvella Therapeutics

Tracked across 1 events · 8 articles · First seen Feb 24, 2026 · Last active Mar 02, 2026

Sentiment
20
Attention
4
Events
1
Relationships
1
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 20
Business
Palvella Therapeutics Upsized Public Offering Closes
Palvella Therapeutics successfully completed an upsized public offering, raising $230 million in gross proceeds. This capital infusion is intended to support the development of its drug programs, including QTORIN rapamycin and QTORIN pitavastatin, and for general corporate purposes, which is a positive for its financial stability and future growth.
Feb 24, 2026 · 8 articles
Relationships (1)
Canaccord Genuity Group===Canaccord Genuity ↔ Palvella Therapeutics Unknown
NEWSDESK
Track Palvella Therapeutics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.